Better Therapeutics Inc.

0.00
-0.00 (-100.00%)
At close: Feb 28, 2025, 2:38 PM
No 1D chart data available
Bid n/a
Market Cap 10.9K
Revenue (ttm) n/a
Net Income (ttm) -92.01M
EPS (ttm) -1.1
PE Ratio (ttm) n/a
Forward PE n/a
Analyst n/a
Ask n/a
Volume 1,010
Avg. Volume (20D) 26,912
Open 0.00
Previous Close 0.00
Day's Range 0.00 - 0.00
52-Week Range 0.00 - 0.22
Beta 1.69

About BTTX

Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also in...

Industry Biotechnology
Sector Healthcare
IPO Date Mar 17, 2021
Employees 54
Stock Exchange NASDAQ
Ticker Symbol BTTX
Full Company Profile